logo

Get Latest Updates

Stay updated with our instant notification.

logo
logo
account_circle Login
BioSpectrum India Magazine
BioSpectrum India Magazine

BioSpectrum India Magazine

By: Bio Spectrum And NuFFooDs Spectrum
100.00

Single Issue

1250.00

12 Months

100.00

Single Issue

1250.00

12 Months

About this issue

Health 4.0- Tailwind for 2019   Today we are at a tipping point in advanced technology adoption. Personalisation coupled with an explosion of digital health are the driving trends in value based care. Pharma, medical device and biotechnology innovators are harnessing digital technology and the power of big data and analytics to deliver a more cost-effective approach to healthcare. According to a recent report by NASSCOM, India has added 1200 more tech startups in 2018 into the total of 7700 that currently exist. Out of these 1200, approximately 150 belong to the health-tech sector. By focusing on accessibility and technology integration in the health sector, health-tech startups in India are playing a crucial role in improving the well–being and health of over a billion Indians. With Industry 4.0 re-defining the health sector, these startups will become the tailwind of healthcare in 2019.

About BioSpectrum India Magazine

The BioSpectrum India edition was launched in March 2003 and is India's first comprehensive biotech business monthly magazine. It provides comprehensive coverage of the exciting happenings in life sciences, which include BioPharma, BioAgriculture, BioInformatics, BioIndustrial, BioSuppliers and BioServices and show cases the emerging Indian entrepreneurships in biotech industry. In a short time BioSpectrum has emerged as the most preferred platform to engage the life sciences industry in India and Asia Pacific. It is also widely accepted by research and academia community. Top key policy makers in the Central and state government use the magazine as a platform to reach out the Indian Biotech Industry. BioSpectrum has columns by Indian's top policy makers, biotechnology professionals, scientists and NGOs. Readers of BioSpectrum are from among the key Policy Makers, Key Executives and the Influencer's in Biotechnology, Pharmaceutical Companies, Research Heads of Clinical Research, Clinical Trials and Contract Mfg Organizations, Educational Institutes, Consultants, Fund Managers etc